280,16 €
311,29 €
-10% with code: EXTRA
Novel Aspects in Acute Lymphoblastic Leukemia
Novel Aspects in Acute Lymphoblastic Leukemia
280,16
311,29 €
  • We will send in 10–14 business days.
Acute lymphoblastic leukemia (ALL) has turned from a universally fatal to a highly curable disease in little more than four decades. Even though differences in outcome continue to exist between children and adults, intense efforts are under way to overcome this discrepancy and improve the prognosis of adult patients as well. This exemplary progress in ALL therapy has been possible by the combination of an increasingly better understanding of the biology of the disease, availability of a range o…
311.29
  • Publisher:
  • ISBN-10: 9533077530
  • ISBN-13: 9789533077536
  • Format: 17 x 24.4 x 1.6 cm, kieti viršeliai
  • Language: English
  • SAVE -10% with code: EXTRA

Novel Aspects in Acute Lymphoblastic Leukemia (e-book) (used book) | bookbook.eu

Reviews

Description

Acute lymphoblastic leukemia (ALL) has turned from a universally fatal to a highly curable disease in little more than four decades. Even though differences in outcome continue to exist between children and adults, intense efforts are under way to overcome this discrepancy and improve the prognosis of adult patients as well. This exemplary progress in ALL therapy has been possible by the combination of an increasingly better understanding of the biology of the disease, availability of a range of effective drugs, and astute designs and relentless executions of many clinical trials. ALL is a complex disease requiring complex therapy. Whereas this book cannot provide a comprehensive review of every one of its many facets, the chapters from many investigators from around the world nevertheless cover a number of relevant topics: aspects of the epidemiology of ALL in Hispanics, ophthalmologic manifestations of ALL, overviews of current therapy and drug-resistance mechanisms, novel biological pathways and targets, new drugs in development, and long-term consequences of CNS prophylaxis and therapy. The publishers and editor therefore hope that the prospective readers will find enough insight and information for their own endeavors.

EXTRA 10 % discount with code: EXTRA

280,16
311,29 €
We will send in 10–14 business days.

The promotion ends in 23d.05:42:58

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 3,11 Book Euros!?
  • Publisher:
  • ISBN-10: 9533077530
  • ISBN-13: 9789533077536
  • Format: 17 x 24.4 x 1.6 cm, kieti viršeliai
  • Language: English English

Acute lymphoblastic leukemia (ALL) has turned from a universally fatal to a highly curable disease in little more than four decades. Even though differences in outcome continue to exist between children and adults, intense efforts are under way to overcome this discrepancy and improve the prognosis of adult patients as well. This exemplary progress in ALL therapy has been possible by the combination of an increasingly better understanding of the biology of the disease, availability of a range of effective drugs, and astute designs and relentless executions of many clinical trials. ALL is a complex disease requiring complex therapy. Whereas this book cannot provide a comprehensive review of every one of its many facets, the chapters from many investigators from around the world nevertheless cover a number of relevant topics: aspects of the epidemiology of ALL in Hispanics, ophthalmologic manifestations of ALL, overviews of current therapy and drug-resistance mechanisms, novel biological pathways and targets, new drugs in development, and long-term consequences of CNS prophylaxis and therapy. The publishers and editor therefore hope that the prospective readers will find enough insight and information for their own endeavors.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)